SciELO - Scientific Electronic Library Online

 
vol.29 issue1Diagnosis of congenital Chagas disease: Relevant aspectsAdjuvant radiotherapy polemic in localized prostate cancer author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Médica de Risaralda

Print version ISSN 0122-0667

Abstract

UEDA, Risa  and  KATAOKA, Hiromitsu. The potential of the antiplatelet agent ticagrelor as a new antibacterial agent. Revista médica Risaralda [online]. 2023, vol.29, n.1, pp.147-156.  Epub Aug 29, 2023. ISSN 0122-0667.  https://doi.org/10.22517/25395203.25126.

The number of deaths caused by drug-resistant bacteria is expected to increase in the future, and there is a need to develop new antimicrobial agents. Recently, the antiplatelet drug ticagrelor has been reported to have promising antibacterial properties. The purpose of this review is to analyze articles and case reports that describe the antimicrobial action of ticagrelor. Ticagrelor was found to have antibacterial reactions against Gram-positive bacteria, including drug-resistant and spore-forming bacteria, while no effect was observed against Gram-negative bacteria. In this paper we discuss a new potential antimicrobial agent, ticagrelor.

Keywords : Ticagrelor; pharmacology; antibacterial resistance; antiplatelet; MRSA; antibiotic.

        · text in English     · English ( pdf )